Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00369408 · ClinicalTrials.gov registry record · Phase 4
Targeted Naltrexone for Problem Drinkers
A Phase 4 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 163
- Enrollment target
NCT00369408 is a Phase 4 study that has completed, run by UConn Health. The registered enrollment target is 163 participants.
The verdict
NCT00369408, a Phase 4 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 163 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether naltrexone, combined with brief coping skills therapy, is effective in the treatment of heavy drinking.
Interventions
- DRUG placebo
- DRUG Naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2003-06 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00369408
The ClinicalTrials.gov registry entry for NCT00369408 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00369408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00369408 about?
NCT00369408 is a clinical study titled "Targeted Naltrexone for Problem Drinkers". The purpose of this study is to determine whether naltrexone, combined with brief coping skills therapy, is effective in the treatment of heavy drinking.
What is the current status of trial NCT00369408?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 163 participants. The study started on 2003-06. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00369408?
The interventions under investigation include: placebo (DRUG), Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00369408?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.